Alcon AG | ALC - Fremdkapital





Fremdkapital Veränderung Datum
AstraZeneca USD 26.01B 46M 2026-06
Bayer EUR 31.16B 480M 2026-06
Essilor EUR 9.66B 190M 2026-06
Fresenius EUR 9.55B 1.24B 2026-06
Fresenius Medical Care EUR 5.82B 83.04M 2026-06
GlaxoSmithKline GBP 13.95B 65M 2026-06
GRIFOLS EUR 7.17B 1.91B 2026-06
Lonza CHF 3.88B 323M 2025-12
Merck EUR 11.21B 406M 2026-06
Novartis USD 37.49B 42M 2026-06
Philips EUR 6.32B 575M 2026-06
Roche Holding CHF 25.22B 2.21B 2026-06
Sanofi EUR 14.65B 806M 2026-06
Smith & Nephew USD 3.21B 85M 2026-06
Sonova Holding CHF 1.39B 209.8M 2025-06
UCB EUR 2.18B 634M 2025-12